Detalhe da pesquisa
1.
Cereblon enhancer methylation and IMiD resistance in multiple myeloma.
Blood
; 138(18): 1721-1726, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115836
2.
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF-MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement.
Oncologist
; 25(2): 112-118, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32043788
3.
Hierarchy of mono- and biallelic TP53 alterations in multiple myeloma cell fitness.
Blood
; 134(10): 836-840, 2019 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31340981
4.
Long non-coding RNAs in haematological malignancies.
Int J Mol Sci
; 14(8): 15386-422, 2013 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23887658
5.
Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma.
Clin Cancer Res
; 29(1): 279-288, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36282272
6.
mRNA-based therapies: Preclinical and clinical applications.
Int Rev Cell Mol Biol
; 372: 1-54, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36064262
7.
Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia.
Commun Biol
; 4(1): 799, 2021 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34172833
8.
Spectrum and functional validation of PSMB5 mutations in multiple myeloma.
Leukemia
; 33(2): 447-456, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30026573
9.
Deregulation of linc-PINT in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cells.
Oncotarget
; 9(16): 12842-12852, 2018 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29560114